Loomis, Sayles & Company’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Sell |
24,481
-44,876
| -65% | -$18.9M | 0.01% | 370 |
|
|
2026
Q1 | $26.2M | Buy |
69,357
+22,311
| +47% | +$9.56M | 0.04% | 187 |
|
|
2025
Q4 | $20.1M | Buy |
47,046
+9,036
| +24% | +$3.93M | 0.02% | 233 |
|
|
2025
Q3 | $17M | Sell |
38,010
-92
| -0.2% | -$41.7K | 0.02% | 261 |
|
|
2025
Q2 | $18.6M | Buy |
38,102
+1,378
| +4% | +$785K | 0.02% | 252 |
|
|
2025
Q1 | $22.6M | Buy |
36,724
+262
| +0.7% | +$149K | 0.03% | 223 |
|
|
2024
Q4 | $19.3M | Buy |
36,462
+7,303
| +25% | +$4.12M | 0.02% | 259 |
|
|
2024
Q3 | $17.5M | Buy |
29,159
+108
| +0.4% | +$61.2K | 0.02% | 278 |
|
|
2024
Q2 | $15.8M | Sell |
29,051
-312
| -1% | -$179K | 0.02% | 286 |
|
|
2024
Q1 | $18.8M | Sell |
29,363
-215
| -0.7% | -$131K | 0.03% | 271 |
|
|
2023
Q4 | $17.3M | Buy |
29,578
+284
| +1% | +$159K | 0.03% | 271 |
|
|
2023
Q3 | $15.2M | Buy |
29,294
+6,013
| +26% | +$3.13M | 0.03% | 274 |
|
|
2023
Q2 | $12.6M | Buy |
23,281
+2,994
| +15% | +$1.64M | 0.02% | 309 |
|
|
2023
Q1 | $10.9M | Buy |
+20,287
| New | +$10.3M | 0.02% | 321 |
|
|
2021
Q2 | – | Sell |
-55,755
| Closed | -$25.6M | – | 840 |
|
|
2021
Q1 | $25.6M | Buy |
55,755
+15
| +0% | +$7.35K | 0.03% | 256 |
|
|
2020
Q4 | $29.7M | Buy |
55,740
+6,613
| +13% | +$3.25M | 0.04% | 210 |
|
|
2020
Q3 | $23.6M | Buy |
49,127
+4,836
| +11% | +$2.37M | 0.03% | 205 |
|
|
2020
Q2 | $20M | Buy |
44,291
+3,403
| +8% | +$1.52M | 0.03% | 221 |
|
|
2020
Q1 | $17.7M | Buy |
40,888
+2,573
| +7% | +$1.15M | 0.04% | 183 |
|
|
2019
Q4 | $16.8M | Buy |
+38,315
| New | +$16.1M | 0.03% | 252 |
|
|
2018
Q1 | – | Sell |
-40
| Closed | -$10K | – | 876 |
|
|
2017
Q4 | $10K | Sell |
40
-5
| -11% | -$1.14K | ﹤0.01% | 778 |
|
|
2017
Q3 | $9K | Hold |
45
| – | – | ﹤0.01% | 794 |
|
|
2017
Q2 | $9K | Sell |
45
-149
| -77% | -$29.7K | ﹤0.01% | 801 |
|
|
2017
Q1 | $35K | Hold |
194
| – | – | ﹤0.01% | 669 |
|
|
2016
Q4 | $31K | Buy |
194
+149
| +331% | +$21.9K | ﹤0.01% | 711 |
|
|
2016
Q3 | $6K | Hold |
45
| – | – | ﹤0.01% | 844 |
|
|
2016
Q2 | $6K | Sell |
45
-71
| -61% | -$9.42K | ﹤0.01% | 816 |
|
|
2016
Q1 | $16K | Buy |
116
+105
| +955% | +$14.2K | ﹤0.01% | 747 |
|
|
2015
Q4 | $2K | Buy |
+11
| New | +$1.63K | ﹤0.01% | 983 |
|
|
2015
Q3 | – | Sell |
-41
| Closed | -$5K | – | 1024 |
|
|
2015
Q2 | $5K | Buy |
+41
| New | +$5.07K | ﹤0.01% | 859 |
|
Other funds holding CHE
EIP
Loomis, Sayles & Company's CHE Position: Q2 2026 in Review
Loomis, Sayles & Company reduced its Chemed (CHE) stake by 65% in Q2 2026, selling an estimated $18.9M and leaving 24,481 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #370.
Loomis, Sayles & Company first reported a position in CHE in Q2 2015 and has held it in 30 quarters since. The position peaked at $29.7M in Q4 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Loomis, Sayles & Company held 24,481 shares of Chemed worth $11.4M as of Q2 2026.
- Loomis, Sayles & Company sold 44,876 Chemed shares in Q2 2026, an estimated $18.9M.
- Chemed made up 0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #370 holding.
- Loomis, Sayles & Company first reported a position in Chemed in Q2 2015 and has held it in 30 quarters since.
- Loomis, Sayles & Company's Chemed position peaked at $29.7M in Q4 2020.
- 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.